Determinants of Diabetes Remission After Gastric Bypass Surgery

NCT02287285 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exendin9

Sponsor

Blandine Laferrere

Collaborators

[object Object]
[object Object]